Caption Management’s Insmed INSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $79M | Buy |
740,700
+640,400
| +638% | +$77.5M | 0.37% | 52 |
|
|
2026
Q1 | $16.4M | Sell |
100,300
-133,900
| -57% | -$20.6M | 0.1% | 227 |
|
|
2025
Q4 | $40.8M | Sell |
234,200
-91,800
| -28% | -$16.8M | 0.28% | 79 |
|
|
2025
Q3 | $46.9M | Buy |
326,000
+43,900
| +16% | +$5.38M | 0.37% | 49 |
|
|
2025
Q2 | $28.4M | Buy |
282,100
+134,300
| +91% | +$10.3M | 0.31% | 60 |
|
|
2025
Q1 | $11.3M | Sell |
147,800
-282,900
| -66% | -$21.6M | 0.11% | 182 |
|
|
2024
Q4 | $29.7M | Buy |
430,700
+4,200
| +1% | +$302K | 0.28% | 48 |
|
|
2024
Q3 | $31.1M | Sell |
426,500
-611,500
| -59% | -$45.1M | 0.5% | 38 |
|
|
2024
Q2 | $69.5M | Buy |
1,038,000
+428,300
| +70% | +$16.6M | 1.07% | 14 |
|
|
2024
Q1 | $16.5M | Buy |
609,700
+595,600
| +4,224% | +$16.7M | 0.25% | 100 |
|
|
2023
Q4 | $437K | Sell |
14,100
-412,000
| -97% | -$10.7M | 0.01% | 990 |
|
|
2023
Q3 | $10.8M | Buy |
426,100
+94,600
| +29% | +$2.16M | 0.17% | 144 |
|
|
2023
Q2 | $6.99M | Buy |
331,500
+223,500
| +207% | +$4.24M | 0.12% | 211 |
|
|
2023
Q1 | $1.84M | Buy |
+108,000
| New | +$2.1M | 0.04% | 462 |
|
|
2022
Q3 | – | Sell |
-30,000
| Closed | -$592K | – | 1666 |
|
|
2022
Q2 | $592K | Hold |
30,000
| – | – | 0.01% | 1032 |
|
|
2022
Q1 | $705K | Buy |
+30,000
| New | +$697K | 0.01% | 1074 |
|
|
2021
Q4 | – | Sell |
-90,000
| Closed | -$2.48M | – | 1753 |
|
|
2021
Q3 | $2.48M | Buy |
90,000
+30,000
| +50% | +$787K | 0.03% | 683 |
|
|
2021
Q2 | $1.71M | Buy |
+60,000
| New | +$1.78M | 0.02% | 730 |
|
|
2020
Q4 | – | Sell |
-30,000
| Closed | -$965K | – | 1107 |
|
|
2020
Q3 | $965K | Buy |
+30,000
| New | +$862K | 0.02% | 628 |
|
|
2020
Q2 | – | Sell |
-14,400
| Closed | -$231K | – | 1066 |
|
|
2020
Q1 | $231K | Sell |
14,400
-33,200
| -70% | -$787K | 0.01% | 682 |
|
|
2019
Q4 | $1.14M | Sell |
47,600
-27,400
| -37% | -$557K | 0.04% | 476 |
|
|
2019
Q3 | $1.32M | Buy |
+75,000
| New | +$1.45M | 0.07% | 325 |
|
|
2019
Q2 | – | Sell |
-30,000
| Closed | -$872K | – | 734 |
|
|
2019
Q1 | $872K | Sell |
30,000
-176,000
| -85% | -$4.56M | 0.05% | 383 |
|
|
2018
Q4 | $2.7M | Buy |
206,000
+3,400
| +2% | +$54.3K | 0.22% | 141 |
|
|
2018
Q3 | $4.1M | Buy |
+202,600
| New | +$4.57M | 0.23% | 124 |
|
Other funds holding INSM
BBA
DGM
OAG
Caption Management's INSM Position: Q2 2026 in Review
Caption Management opened a new position in Insmed (INSM) in Q2 2026: 236,000 shares worth $25.2M. The stake represents 0.12% of the portfolio and ranks #180 among its holdings. This is a return to the name: Caption Management previously reported a position in INSM as recently as Q4 2025.
Caption Management first reported a position in INSM in Q4 2018 and has held it in 20 quarters since. 665 funds tracked by Wall St. Rank hold INSM as of Q2 2026.
- Caption Management held 236,000 shares of Insmed worth $25.2M as of Q2 2026.
- Insmed was a new Caption Management position in Q2 2026.
- Insmed made up 0.12% of Caption Management's portfolio in Q2 2026, its #180 holding.
- Caption Management first reported a position in Insmed in Q4 2018 and has held it in 20 quarters since.
- 665 funds tracked by Wall St. Rank held Insmed as of Q2 2026.
Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.